University College London Hospitals NHS Foundation Trust:企業の戦略的SWOT分析

◆英語タイトル:University College London Hospitals NHS Foundation Trust - Strategic SWOT Analysis Review
◆商品コード:DATA904C14231
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

University College London Hospitals NHS Foundation Trust – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

University College London Hospitals NHS Foundation Trust (UCLH) is a non-profit organization that offers patient care, education and research to fulfill the healthcare requirements of patients and communities. The trust offers acute care and specialist services in hospitals in central London, including University College Hospital (UCH), the Macmillan Cancer Centre, and the University College Hospital at Westmoreland Street; Royal London Hospital for Integrated Medicine; Royal National Throat, Nose and Ear Hospital; Institute of Sport, Exercise and Health; Hospital for Tropical Diseases; National Hospital for Neurology and Neurosurgery at Queen Square, Cleveland Street and Chalfont; and The Eastman Dental Hospital. It serves patients of England and Wales. It provides acute and specialist services. UCLH is headquartered in London, the UK.

University College London Hospitals NHS Foundation Trust Key Recent Developments

Feb 05,2019: Four Progressive Hospitals in Europe Choose Hyland Healthcare for Connected Enterprise Solutions
Apr 12,2018: Grail to initiate largest ever UK cancer screening study

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
University College London Hospitals NHS Foundation Trust – Key Facts
University College London Hospitals NHS Foundation Trust – Key Employees
University College London Hospitals NHS Foundation Trust – Key Employee Biographies
University College London Hospitals NHS Foundation Trust – Major Products and Services
University College London Hospitals NHS Foundation Trust – History
University College London Hospitals NHS Foundation Trust – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
University College London Hospitals NHS Foundation Trust – Business Description
Product Category: Clinical Commissioning Groups (CCG) and NHS England
Performance
Product Category: NHS Foundation Trusts
Performance
Product Category: NHS Injury scheme (previously RTA)
Performance
Product Category: NHS Other
Performance
Product Category: NHS Trusts
Performance
Product Category: Non-NHS: Overseas Patients (Chargeable to Patient)
Performance
Product Category: Non-NHS: Private Patients
Performance
Product Category: A&E Income
Performance
Product Category: Elective income
Performance
Product Category: First Outpatient Income
Performance
Product Category: Follow Up Outpatient Income
Performance
Product Category: High Cost Drugs Income from Commissioners (Excluding Pass-through Costs)
Performance
Product Category: Non Elective Income
Performance
Product Category: Other Clinical Income
Performance
Product Category: Other NHS Clinical Income
Performance
Product Category: Paying Patient Income
Performance
University College London Hospitals NHS Foundation Trust – Corporate Strategy
University College London Hospitals NHS Foundation Trust – SWOT Analysis
SWOT Analysis – Overview
University College London Hospitals NHS Foundation Trust – Strengths
University College London Hospitals NHS Foundation Trust – Weaknesses
University College London Hospitals NHS Foundation Trust – Opportunities
University College London Hospitals NHS Foundation Trust – Threats
Section 3 – Company’s Lifesciences Financial Deals and Alliances
University College London Hospitals NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
University College London Hospitals NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
University College London Hospitals NHS Foundation Trust, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 05, 2019: Four Progressive Hospitals in Europe Choose Hyland Healthcare for Connected Enterprise Solutions
Apr 12, 2018: Grail to initiate largest ever UK cancer screening study
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
University College London Hospitals NHS Foundation Trust, Key Facts
University College London Hospitals NHS Foundation Trust, Key Employees
University College London Hospitals NHS Foundation Trust, Key Employee Biographies
University College London Hospitals NHS Foundation Trust, Major Products and Services
University College London Hospitals NHS Foundation Trust, History
University College London Hospitals NHS Foundation Trust, Joint Venture
University College London Hospitals NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
University College London Hospitals NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
University College London Hospitals NHS Foundation Trust, Recent Deals Summary

List of Figures
University College London Hospitals NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
University College London Hospitals NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[University College London Hospitals NHS Foundation Trust:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sharjah Insurance Company P.S.C.:企業の戦略・SWOT・財務情報
    Sharjah Insurance Company P.S.C. - Strategy, SWOT and Corporate Finance Report Summary Sharjah Insurance Company P.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nationale-Nederlanden Levensverzekering Maatschappij N.V.:企業の戦略・SWOT・財務情報
    Nationale-Nederlanden Levensverzekering Maatschappij N.V. - Strategy, SWOT and Corporate Finance Report Summary Nationale-Nederlanden Levensverzekering Maatschappij N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the co …
  • Aquestive Therapeutics Inc (AQST):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquestive Therapeutics Inc (Aquestive Therapeutics) is a pharmaceutical company that discovers, develops and commercializes prescription drug products and a pipeline of prescription formulations. The company offers PharmFilm a drug delivery platform that delivers existing prescription produc …
  • Repsol SA (REP):企業の財務・戦略的SWOT分析
    Repsol SA (REP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Express Scripts Holding Co (ESRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and m …
  • Verbund AG:企業の発電所・SWOT分析2018
    Verbund AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • MyoKardia Inc (MYOK):企業の財務・戦略的SWOT分析
    MyoKardia Inc (MYOK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Monica Healthcare Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Monica Healthcare Ltd (MHL), a subsidiary of GE Healthcare LLC, is a medical device company that develops and commercializes fetal monitoring devices for use during labor and uterine activity applications. The company provides products such as monica AN24 with IF24, monica AN24 with VS progr …
  • Alliant Energy Corp (LNT):企業の財務・戦略的SWOT分析
    Alliant Energy Corp (LNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • LVMH Moet Hennessy Louis Vuitton SA:戦略・SWOT・企業財務分析
    LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report Summary LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Anadolubank A.S.:企業の戦略・SWOT・財務情報
    Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report Summary Anadolubank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Equifax Inc.:企業の戦略・SWOT・財務分析
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Karambunai Corporation Berhad:戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Snap-on Inc (SNA):企業の財務・戦略的SWOT分析
    Snap-on Inc (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Power Corporation of Canada:企業の戦略・SWOT・財務分析
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Firalis SAS:企業の製品パイプライン分析2018
    Summary Firalis SAS (Firalis) is a biotechnology company that develops biomarkers and biomarker-based diagnostic kits. The company’s biomarker products comprise recombinant proteins and calibrants, Elisa kits, and monoclonal antibodies, among others. It offers biomarker services such as flow cytomet …
  • Elsalys Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The company's pipeline programs include anti-CD160, for macular degeneration or certain retinopathie …
  • Wagamama Limited :企業の戦略・SWOT・財務情報
    Wagamama Limited - Strategy, SWOT and Corporate Finance Report Summary Wagamama Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆